CHAPTER 1 INTRODUCTION
1.1 Report description
1.2 Key benefits
1.3 Key market segments
1.4 Research methodology
1.4.1 Secondary research
1.4.2 Primary research
1.4.3 Analyst tools and models
CHAPTER 2 EXECUTIVE SUMMARY
2.1 CXO perspective
CHAPTER 3 MARKET OVERVIEW
3.1 Market definition and scope
3.2 Key findings
3.2.1 Top investment pockets
3.2.2 Top winning strategies
3.3 Porters five forces analysis
3.3.1 Low bargaining power of suppliers
3.3.2 Moderate bargaining power of buyers
3.3.3 Moderate threat of new entrants
3.3.4 Moderate threat of substitutes
3.3.5 High competitive rivalry
3.4 Market dynamics
3.4.1 Drivers
3.4.1.1 High prevalence of PAD, AMI, DVT & PE conditions
3.4.1.2 Rise in geriatric population
3.4.1.3 Growing demand of minimally invasive procedures
3.4.1.4 Better healthcare infrastructure
3.4.1.5 High competiton among key players
3.4.2 Restraints
3.4.2.1 Lack of trained professionals and awareness
3.4.2.2 High cost and complicated use of thrombectomy devices
3.4.3 Opportunities
3.4.3.1 Introductin of lasers and uv radiation, and 3D imaging generation in thrombectomy devices
3.4.3.2 Combination of decompressive surgery and thrombectomy
CHAPTER 4 WORLD THROMBECTOMY DEVICES MARKET, BY TECHNOLOGY, 2014-2022
4.1 Overview
4.1.1 Market size and forecast
4.2 Mechanical thrombectomy devices
4.2.1 Key market trends
4.2.2 Key growth factors and opportunities
4.2.3 Market size and forecast
4.3 Aspiration thrombectomy devices
4.3.1 Key market trends
4.3.2 Key growth factors and opportunities
4.3.3 Market size and forecast
4.4 Rheolytic thrombectomy devices
4.4.1 Key market trends
4.4.2 Key growth factors and opportunities
4.4.3 Market size and forecast
CHAPTER 5 WORLD THROMBECTOMY DEVICES MARKET, BY TYPE, 2014-2022
5.1 Overview
5.1.1 Market size and forecast
5.2 Automated devices
5.2.1 Key market trends
5.2.2 Key growth factors and opportunities
5.2.3 Market size and forecast
5.3 Manual devices
5.3.1 Key market trends
5.3.2 Key growth factors and opportunities
5.3.3 Market size and forecast
CHAPTER 6 WORLD THROMBECTOMY DEVICES MARKET, BY UTILITY, 2014-2022
6.1 Overview
6.1.1 Market size and forecast
6.2 Reusable devices
6.2.1 Key market trends
6.2.2 Key growth factors and opportunities
6.2.3 Market size and forecast
6.3 Disposable devices
6.3.1 Key market trends
6.3.2 Key growth factors and opportunities
6.3.3 Market size and forecast
CHAPTER 7 WORLD THROMBECTOMY DEVICES MARKET, BY DISEASES, 2014-2022
7.1 Overview
7.1.1 Market size and forecast
7.2 Peripheral Diseases
7.2.1 Key market trends
7.2.2 Key growth factors and opportunities
7.2.3 Market size and forecast
7.3 Coronary Diseases
7.3.1 Key market trends
7.3.2 Key growth factors and opportunities
7.3.3 Market size and forecast
7.4 Neural Diseases
7.4.1 Key market trends
7.4.2 Key growth factors and opportunities
7.4.3 Market size and forecast
CHAPTER 8 WORLD THROMBECTOMY DEVICES MARKET, BY GEOGRAPHY, 2014-2022
8.1 Overview
8.1.1 Market size and forecast
8.2 North America
8.2.1 Key market trends
8.2.2 Key growth factors and opportunities
8.2.3 Market size and forecast
8.2.3.1 U.S. Market size and forecast
8.2.3.2 Canada Market size and forecast
8.2.3.3 Mexcio Market size and forecast
8.3 Europe
8.3.1 Key market trends
8.3.2 Key growth factors and opportunities
8.3.3 Market size and forecast
8.3.3.1 Germany Market Size And Forecast
8.3.3.2 France Market Size And Forecast
8.3.3.3 U.K. Market Size And Forecast
8.3.3.4 Italy Market Size And Forecast
8.3.3.5 Spain Market Size And Forecast
8.3.3.6 Rest Of Europe Market Size And Forecast
8.4 Asia-Pacific
8.4.1 Key market trends
8.4.2 Key growth factors and opportunities
8.4.3 Market size and forecast
8.4.3.1 Japan Market size and forecast
8.4.3.2 China Market size and forecast
8.4.3.3 India Market size and forecast
8.4.3.4 Rest of Asia-Pacific Market size and forecast
8.5 Latin America, Middle East, Africa (LAMEA)
8.5.1 Key market trends
8.5.2 Key growth factors and opportunities
8.5.3 Market size and forecast
8.5.3.1 Brazil Market size and forecast
8.5.3.2 Saudi Arabia Market size and forecast
8.5.3.3 South Africa Market size and forecast
8.5.3.4 Rest of lamea Market size and forecast
CHAPTER 9 COMPANY PROFILES
9.1 Boston Scientific Corporation
9.1.1 Company overview
9.1.2 Company snapshot
9.1.3 Operating business segments
9.1.4 Business performance
9.1.5 Key strategic moves & developments
9.2 Medtronic Plc
9.2.1 Company overview
9.2.2 Company snapshot
9.2.3 Operating business segments
9.2.4 Business performance
9.2.5 Key strategic moves & developments
9.3 Teleflex Incorporated
9.3.1 Company overview
9.3.2 Company snapshot
9.3.3 Operating business segments
9.3.4 Business performance
9.3.5 Key strategic moves & developments
9.4 Terumo Corporation
9.4.1 Company overview
9.4.2 Company snapshot
9.4.3 Operating business segments
9.4.4 Business performance
9.4.5 Key strategic moves & developments
9.5 Penumbra, Inc.
9.5.1 Company overview
9.5.2 Company snapshot
9.5.3 Operating business segments
9.5.4 Business performance
9.5.5 Key strategic moves & developments
9.6 The Spectranetics Corporation
9.6.1 Company overview
9.6.2 Company snapshot
9.6.3 Operating business segments
9.6.4 Business performance
9.6.5 Key strategic moves & developments
9.7 AngioDynamics, Inc.
9.7.1 Company overview
9.7.2 Company snapshot
9.7.3 Operating business segments
9.7.4 Business performance
9.7.5 Key strategic moves & developments
9.8 Vascular Solutions, Inc.
9.8.1 Company overview
9.8.2 Company snapshot
9.8.3 Operating business segments
9.8.4 Business performance
9.8.5 Key strategic moves & developments
9.9 Johnson & Johnson, Inc.
9.9.1 Company overview
9.9.2 Company snapshot
9.9.3 Operating business segments
9.9.4 Business performance
9.9.5 Key strategic moves & developments
9.10 Stryker Corporation
9.10.1 Company Overview
9.10.2 Company Snapshot
9.10.3 Operating business segments
9.10.4 Business performance
9.10.5 Key strategic moves & developments
